# Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers

> **NCT02618837** · PHASE4 · UNKNOWN · sponsor: **University of Padova** · enrollment: 2520 (estimated)

## Conditions studied

- Unstable Angina or Non ST Elevated Myocardial Infarction

## Interventions

- **PROCEDURE:** Downstream strategy
- **PROCEDURE:** Upstream strategy

## Key facts

- **NCT ID:** NCT02618837
- **Lead sponsor:** University of Padova
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12-14
- **Primary completion:** 2021-06
- **Final completion:** 2022-08
- **Target enrollment:** 2520 (ESTIMATED)
- **Last updated:** 2020-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02618837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02618837, "Downstream Versus Upstream Strategy for the Administration of P2Y12 Receptor Blockers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02618837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*